Replies to post #798220 on NorthWest Biotherapeutics Inc (NWBO)

[AllSheWrote]

Every NWBO investor eventually has their "Aha!" moment. For some it just comes later than others. And then there are those for whom it comes too late.

[Investor082]

Keep an open mind about your exit strategy. It may never get to $1, forget about $2. Take what the markets give and get the hell out, if you think you’d be better off investing in a solid management that has a history of delivering consistent returns to shareholders rather than the mute, inept, and lying crew running this company.

As soon as the vote is announced for an increase in authorized share count, you can bet that the downward spiral will officially begin and the 3rd generation of shareholders will be wiped out!

[HyGro]

BP don't do deals with OTC biotech drug companies. Investigating over the last decade, it doesn't happen. Merck has had plenty of access to DCVax-L data with their SPORE UCLA trials. But yet, Merck has repeatedly passed up NWBO. BP don't trust OTC biotech drug companies. Too many other quality options to chose from and Merck done multiple deals with oncology companies. BP has had a decade for deals to be done and so far crickets. ALL the data is available and nobody is interested. If that's your investment objective, sorry, ain't going to happen.